| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
(Circulation. 1997;95:2416-2422.)
© 1997 American Heart Association, Inc.
Articles |
the Department of Cardiac Diseases, San Filippo Neri Hospital, and Arrhythmia Control Unit (M.V.), I Clinica Medica La Sapienza Univerisity, Rome, Italy.
Correspondence to Dr Claudio Pandozi, Via Madonna Di Fatima, 22, 00147 Roma, Italy.
Background Atrial fibrillation (AF) is considered to be maintained by multiple reentrant circuits without or with a very short excitable gap. However, the possibility of local atrial capture has been shown recently in experimental AF or induced AF in humans.
Methods and Results This study was undertaken to evaluate the feasibility of atrial capturesuggestive of an excitable gapin spontaneous chronic AF. Decremental pacing was performed in 47 right atrial sites in 14 patients with chronic AF, not taking antiarrhythmic drugs. A Franz catheter (for pacing and monophasic action potential recording) and a recording quadripolar catheter positioned about 10 mm apart were used. Local capture was achieved in 41 (87.2%) sites for a total of 100 captures. In 71 episodes the capture was lost within 15 seconds, while in the remaining 29, pacing was stopped after 15 seconds of stable capture. The AF types immediately before capture were type 1 in 83 and type 2 in 17 episodes. Type 3 AF was never captured. Pacing cycle at capture was 175.7±20.9 ms. The baseline atrial interval (FF) was 185.4±24.5, significantly longer than the FF recorded during pacing immediately before capture (176.0±19.8 ms) (P<.02).
Conclusions During spontaneous chronic AF in humans, (1) local capture by atrial pacing is possible up to at least 15 mm from the pacing site, (2) regional entrainment is possible during type 1 and type 2 AF but not type 3 AF, and (3) pacing before capture accelerates AF, probably by transient or local capture. These findings suggest that an excitable gap is present in chronic AF, therefore supporting the hypothesis that leading circle reentry is not the unique electrophysiological mechanism maintaining the arrhythmia.
Key Words: fibrillation atrium arrhythmia reentry
This article has been cited by other articles:
![]() |
A. J. Camm, P. Kirchhof, G. Y.H. Lip, I. Savelieva, and S. Ernst CHAPTER 29 Atrial Fibrillation ESC Textbook of Cardiovascular Medicine, January 1, 2009; 2(1): med-9780199566990-chapter - med-9780199566990-chapter. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Gulizia, S. Mangiameli, S. Orazi, G. Chiaranda, G. Boriani, G. Piccione, N. DiGiovanni, A. Colletti, C. Puntrello, G. Butera, et al. Randomized comparison between Ramp and Burst+ atrial antitachycardia pacing therapies in patients suffering from sinus node disease and atrial fibrillation and implanted with a DDDRP device Europace, July 1, 2006; 8(7): 465 - 473. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. G. KLEBER and Y. RUDY Basic Mechanisms of Cardiac Impulse Propagation and Associated Arrhythmias Physiol Rev, April 1, 2004; 84(2): 431 - 488. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Ricci, C. Pignalberi, M. Disertori, A. Capucci, L. Padeletti, G. Botto, S. Toscano, F. Miraglia, A. Grammatico, and M. Santini Efficacy of a dual chamber defibrillator with atrial antitachycardia functions in treating spontaneous atrial tachyarrhythmias in patients with life-threatening ventricular tachyarrhythmias Eur. Heart J., September 2, 2002; 23(18): 1471 - 1479. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Disertori, L. Padeletti, M. Santini, P. Dini, M. Gasparini, G. Inama, M. Botto, G. Boriani, A. Capucci, R. Ricci, et al. Antitachycardia pacing therapies to terminate atrial tachyarrhythmias: the AT500 Italian Registry Eur. Heart J. Suppl., November 1, 2001; 3(suppl_P): P16 - P24. [Abstract] [PDF] |
||||
![]() |
R. Ricci, C. Pignalberil, M. Disertori, A. Capucci, L. Padeletti, G. Botto, G. Boriani, F. Miraglia, T. de Santo, and M. Santini Antitachycardia pacing therapy to treat spontaneous atrial tachyarrhythmias: the 7250 dual defibrillator Italian Registry Eur. Heart J. Suppl., November 1, 2001; 3(suppl_P): P25 - P32. [Abstract] [PDF] |
||||
![]() |
S. W. Adler II, C. Wolpert, E. N. Warman, S. K. Musley, J. L. Koehler, and D. E. Euler Efficacy of Pacing Therapies for Treating Atrial Tachyarrhythmias in Patients With Ventricular Arrhythmias Receiving a Dual-Chamber Implantable Cardioverter Defibrillator Circulation, August 21, 2001; 104(8): 887 - 892. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Duytschaever, F. Mast, M. Killian, Y. Blaauw, M. Wijffels, and M. Allessie Methods for Determining the Refractory Period and Excitable Gap During Persistent Atrial Fibrillation in the Goat Circulation, August 21, 2001; 104(8): 957 - 962. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Shinagawa, H. Mitamura, A. Takeshita, T. Sato, H. Kanki, S. Takatsuki, and S. Ogawa Determination of refractory periods and conduction velocity during atrial fibrillation using atrial capture in dogs: Direct assessment of the wavelength and its modulation by a sodium channel blocker, pilsicainide J. Am. Coll. Cardiol., January 1, 2000; 35(1): 246 - 253. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. R Franz Current status of monophasic action potential recording: theories, measurements and interpretations Cardiovasc Res, January 1, 1999; 41(1): 25 - 40. [Full Text] [PDF] |
||||
|
Circulation Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 1997 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |